Aura Biosciences, Inc. Common Stock (AURA) is a publicly traded Healthcare sector company. As of May 21, 2026, AURA trades at $8.00 with a market cap of $772.30M and a P/E ratio of -4.26. AURA moved +1.15% today. Year to date, AURA is +44.21%; over the trailing twelve months it is +25.97%. Its 52-week range spans $4.35 to $12.38. Analyst consensus is strong buy with an average price target of $19.75. Rallies surfaces AURA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for AURA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $8.00 |
| Market Cap | $772.30M |
| P/E Ratio | -4.26 |
| EPS | $-1.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.38 |
| 52-Week Low | $4.35 |
| Volume | 444.64K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-106.19M |
| Gross Margin | 0.00% |
5 analysts cover AURA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.75.